CA2608189A1 - Administration a faible dose d'une composition topique - Google Patents

Administration a faible dose d'une composition topique Download PDF

Info

Publication number
CA2608189A1
CA2608189A1 CA002608189A CA2608189A CA2608189A1 CA 2608189 A1 CA2608189 A1 CA 2608189A1 CA 002608189 A CA002608189 A CA 002608189A CA 2608189 A CA2608189 A CA 2608189A CA 2608189 A1 CA2608189 A1 CA 2608189A1
Authority
CA
Canada
Prior art keywords
individual
composition
testosterone
active ingredient
delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002608189A
Other languages
English (en)
Inventor
Thomas Chan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Macrochem Corp
Original Assignee
Macrochem Corporation
Thomas Chan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Macrochem Corporation, Thomas Chan filed Critical Macrochem Corporation
Publication of CA2608189A1 publication Critical patent/CA2608189A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002608189A 2005-05-11 2006-05-04 Administration a faible dose d'une composition topique Abandoned CA2608189A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US67967305P 2005-05-11 2005-05-11
US60/679,673 2005-05-11
PCT/US2006/016831 WO2006124275A2 (fr) 2005-05-11 2006-05-04 Administration a faible dose d'une composition topique

Publications (1)

Publication Number Publication Date
CA2608189A1 true CA2608189A1 (fr) 2006-11-23

Family

ID=37431780

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002608189A Abandoned CA2608189A1 (fr) 2005-05-11 2006-05-04 Administration a faible dose d'une composition topique

Country Status (7)

Country Link
EP (1) EP1879593A2 (fr)
JP (1) JP2009504566A (fr)
AU (1) AU2006247934A1 (fr)
CA (1) CA2608189A1 (fr)
MX (1) MX2007013912A (fr)
TW (1) TW200722092A (fr)
WO (1) WO2006124275A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6863832B2 (ja) * 2016-07-21 2021-04-21 日清ファルマ株式会社 筋萎縮抑制用組成物
US20230041289A1 (en) * 2021-08-05 2023-02-09 Innovus Pharmaceuticals, Inc. Compositions and methods for enhancing or treating female sexual response

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861764A (en) * 1986-11-17 1989-08-29 Macro Chem. Corp. Percutaneous absorption enhancers, compositions containing same and method of use
US5849729A (en) * 1995-12-26 1998-12-15 Hershey Foods Corporation Use of hydrolyzed cocoa butter for percutaneous absorption

Also Published As

Publication number Publication date
JP2009504566A (ja) 2009-02-05
AU2006247934A1 (en) 2006-11-23
TW200722092A (en) 2007-06-16
EP1879593A2 (fr) 2008-01-23
MX2007013912A (es) 2008-03-25
WO2006124275A3 (fr) 2009-04-09
WO2006124275A2 (fr) 2006-11-23

Similar Documents

Publication Publication Date Title
US9180194B2 (en) Method and composition for transdermal drug delivery
US6299900B1 (en) Dermal penetration enhancers and drug delivery systems involving same
US20070190019A1 (en) Compositions and methods for topical administration
US20090098069A1 (en) Transdermal, alcohol-free, pharmaceutical compositions
CA2610708C (fr) Methode et composition pour l'administration transdermique d'un medicament
WO2005056103A1 (fr) Methode de traitement d'un effet indesirable suite a la liberation d'un medicament au niveau transdermique ou topique
CA2608189A1 (fr) Administration a faible dose d'une composition topique
AU2011202787B2 (en) Method and composition for transdermal drug delivery
AU2006254742B2 (en) Method and composition for transdermal drug delivery

Legal Events

Date Code Title Description
FZDE Dead